Breaking barriers: NEK2 inhibition shines in multiple myeloma treatment

Lischer C, Bruns H (2023)

Publication Type: Journal article

Publication year: 2023

Journal

Cell Reports Medicine Elsevier

Book Volume: 4

Article Number: 101237

Journal Issue: 10

DOI: 10.1016/j.xcrm.2023.101237

Abstract

In their article, Cheng et al.¹ reveal that NEK2 loss reshapes the tumor microenvironment, reducing tumor-associated macrophages and decreasing T cell exhaustion. They show that this ultimately favors the immune system's anti-cancer response in multiple myeloma.

Authors with CRIS profile

Christopher Lischer Department of Dermatology Heiko Bruns Department of Medicine 5 – Haematology and Oncology

How to cite

APA:

Lischer, C., & Bruns, H. (2023). Breaking barriers: NEK2 inhibition shines in multiple myeloma treatment. Cell Reports Medicine, 4(10). https://doi.org/10.1016/j.xcrm.2023.101237

MLA:

Lischer, Christopher, and Heiko Bruns. "Breaking barriers: NEK2 inhibition shines in multiple myeloma treatment." Cell Reports Medicine 4.10 (2023).

BibTeX: Download